clinical trial · NCT04486313
Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19
Romark Laboratories L.C.·phase3·completed·n = 935
COVID-19NitazoxanidePlaceboVitamin Super B-Complex
brief summary
Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19
started
Aug 13, 2020
primary completion
Feb 8, 2021
completion
Feb 8, 2021
last updated
Mar 29, 2024
detailed description
Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19
official title
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol